Protective effect of single-dose adjuvanted pandemic influenza vaccine in children

Influenza and other Respiratory Viruses

Volumn 4, Issue 4, 2010, Pages 171-178

  Van Buynder, P G ^a,b   Dhaliwal, J K ^c   Van Buynder, J L ^c   Couturier, C ^c   Minville LeBlanc, M ^c   Garceau, R ^d   Tremblay, F W ^c  

^a New Brunswick Department of Health   (Canada)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c OCMOH   (Canada)

^d Georges Dumont Hospital Laboratory   (Canada)

Author keywords

Adjuvanted; Effectiveness; Influenza; Paediatric; Pandemic; Vaccination

Indexed keywords

ADJUVANT; AREPANRIX; INFLUENZA VACCINE; UNCLASSIFIED DRUG;

ARTICLE; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; INFECTION PREVENTION; INFLUENZA; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; MAJOR CLINICAL STUDY; MALE; PANDEMIC; PRIORITY JOURNAL; SINGLE DRUG DOSE; TREATMENT OUTCOME;

ADJUVANTS, IMMUNOLOGIC; CANADA; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; FEMALE; HUMANS; IMMUNIZATION SCHEDULE; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; PANDEMICS; TREATMENT OUTCOME; VACCINATION;

EID: 77954482419     PISSN: 17502640     EISSN: 17502659     Source Type: Journal    
DOI: 10.1111/j.1750-2659.2010.00146.x     Document Type: Article

References (13)

1. Baker MG, Kelly H, Wilson N. Pandemic H1N1 influenza lessons from the southern hemisphere. Euro Surveill 2009, 14(42). http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19370, pii=19370. Available online:
2. Progression and impact of the first winter wave of the 2009 pandemic H1N1 influenza in New South Wales, Australia. Euro Surveill 2009, 14(42). http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19365, pii=19365. Available online:
3. Smith S, Demicheli V, Di Pietrantonj C. Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev 2006, CD004879
4. http://www.gsk-clinicalstudyregister.com/files/pdf/27868.pdf
5. http://www.gsk.ca/english/docs-pdf/Arepanrix_PIL_CAPA01v01.pdf
6. Fouchier RAM, Bestebroer TM, Herfst S. Detection of Influenza A viruses from different species by PCR amplification of conserved sequences in the matrix gene. J Clin Microbiol 2000, 38(11):4096-4101.
7. http://www.emea.europa.eu/pdfs/general/direct/pr/78440409en.pdf
8. http://www.dhsspsni.gov.uk/hss-md-58-2009.pdf
9. Orenstein EW, De Serres G, Haber MJ. Methodological issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol 2007, 36:623-631.
10. http://www.ecdc.europa.eu/en/publications/Publications/0907_TED_Influenza_AH1N1_Measuring_Influenza_Vaccine_Effectiveness_Protocol_Case_Control_Studies.pdf
11. Loeb M, Russell ML, Moss L. Effect of influenza vaccination of children on infection rates in Hutterite communities. JAMA 2010, 303(10):943-950.
12. Farrington CP. Estimation of vaccine effectiveness using the screening method. Int J Epidemiol 1993, 22(4):742-746.
13. Wichmann O, Stocker P, Poggensee G. Pandemic Influenza A(H1N1) 2009 breakthrough infections and estimates of vaccine effectiveness in Germany 2009-2010. Euro Surveill 2010, 15(18). http://www.eurosurveillance.org/ViewArticle.aspx?Articleld=19561, pii=19561. Available online: